中药药效物质与作用机制研究。

1.Shen Y, Fan XT, Qu YH, Tang M, Huang YH, Peng Y, Fu Q*, Magnoflorine attenuates inflammatory responses in RA by regulating the PI3K/Akt/NF-κB and Keap1-Nrf2/HO-1 signalling pathways in vivo and in vitro. Phytomedicine, 2022, 104: 154339.
2.Yang LF, Teng L, Fu Q*, Undescribed ecdysteroids and phenolic glycosides from the roots of Cyathula officinalis Kuan and their anti-inflammatory activity in LPS-induced RAW 264.7 macrophages in vitro, Phytochemistry 2022, 196: 113101.
3.Qu YH, Shen Y, Teng L, Huang YH, Yang YT, Jian X, Fan SL, Wu P*, Fu Q*, Chicoric acid attenuates tumor necrosis factor-α-induced inflammation and apoptosis via the Nrf2/HO-1, PI3K/AKT and NF-κB signaling pathways in C28/I2 cells and ameliorates the progression of osteoarthritis in a rat model. International Immunopharmacology, 2022,111: 109129..
4.Shen Y, Teng L, Qu YH, Huang YH, Peng Y, Tang Min, Fu Q*, Hederagenin Suppresses Inflammation and Cartilage Degradation to Ameliorate the Progression of Osteoarthritis: An In vivo and In vitro Study. Inflammation, doi: 10.1007/s10753-022-01763-5..
5.Shen Y, Teng L, Qu YH, Fu Q*, Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways. Journal of Ethnopharmacology 2022, 284:114791..
6.Teng L, Shen Y, Qu YH, Yang LF, Yang YT, Jian X, Fan SL, Zhang LL*, Fu Q*, Cyasterone inhibits IL-1β-mediated apoptosis and inflammation via the NF-κB and MAPK signalling pathways in rat chondrocytes and ameliorates osteoarthritis in vivo, Chinese Journal of Natural Medicines, 2023, 21: 1-14..
7.Jiang YP, Zheng YF, Dong Q, Liao W, Pang L, Chen J, He QM, Zhang JM, Luo YH, Li JX, Fu CM *, Fu Q**, Metabolomics combined with network pharmacology to study the mechanism of Shentong Zhuyu decoction in the treatment of rheumatoid arthritis. Journal of Ethnopharmacology 2022, 285:114846..
8.Fu Q*, Yang M, Ma Y, Chen J, Yuan HM, Novel triterpene saponins isolated from Clematis mandshurica and their inhibitory activities on NO production. Chinese Journal of Nature medicines. 2018,16(2): 0131-0138..
9.Wang B, Guang CY, Fu Q*, The traditional uses, secondary metabolites, and pharmacology of Lycopodium species. Phytochemistry Reviews, 2022, 21: 1-79..
10.Huang YH, Li JT, Zan K**, Wang J***, Fu Q*, The traditional uses, secondary metabolites, and pharmacology of Eleutherococcus species. Phytochemistry Reviews, 2022, 21:1081–1184..

1.国家自然科学基金-面上项目，基于原位靶点钩钓研究栀子抗湿热痹阻型RA软骨损伤的直接靶点和分子机制，主持
2.国家自然科学基金-面上项目，基于抑制OA软骨退行性病变研究威灵仙治疗风湿骨痹的物质基础协同显效机制，主持
3.国家自然科学基金-青年基金，基于“抑制滑膜血管新生”研究威灵仙“通络治痹”的物质基础与机制，主持
4.四川省教育厅创新团队，中药药效物质与质量控制，主持
5.四川省自然科学基金-面上项目，基于调节滑膜微环境研究“制川乌-白芍”对药 “开痹通络”的物质基础及机制，主持
6.成都市重点研发计划，基于转录组学的川产道地药材治疗关节炎药效物质发现与作用机制研究，主持
7.成都大学高层次人才基金,单面针抗炎的物质基础和作用机制研究，主持
8.教育部科学技术进步奖二等奖，基于活性成分的中药质量控制创新体系及其应用
9.四川省教学成果奖二等奖，基于“四个融合”培养“德、理、技、创” 生物医药产业人才的探索与实践（排名第二）